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Orexin-A and -B (also known as hypocretin 1 and hypocretin 2)
are neuropeptides expressed exclusively by the neurones of the
lateral hypothalamic area (LHA) (1, 2). Orexin-producing neurones
(orexin neurones) project throughout the brain. Dense projections
of orexin neurones are observed in the serotonergic dorsal raphe
nucleus (DR), noradrenergic locus coeruleus (LC) and histaminergic
tuberomammillary nucleus (TMN), and all of these nuclei are
involved in promoting arousal. Although orexin mRNA is not
expressed in the pituitary gland (3), orexin-positive nerve endings
have been detected in the pituitary gland and paraventricular
nucleus (4).
Orexin receptor-1 and -2 (OX1R and OX2R) are G-protein cou-
pled receptors, and orexin binding is excitatory for postsynaptic
cells (4–8). The effects of orexin on feeding behaviour were exam-
ined shortly after its discovery because the site of orexin neuro-
nes (i.e. the lateral hypothalamic area) is considered to be a
feeding centre. Intracerebroventricular injection of orexin induced
feeding behaviour, and food deprivation increased levels of prep-
ro-orexin mRNA in rats (1, 9). Co-administration of the neuropep-
tide Y (NPY) Y1 receptor selective antagonist BIBO3304
signiﬁcantly reduced orexin-induced feeding behaviour, indicating
that orexin-induced increases in food intake were partially medi-
ated through the NPY pathway (9). Thus, there are good data
available indicating that orexin plays a role in regulating feeding
behaviour; however, mice lacking the orexin peptide (prepro-orexin
knockout mice) or OX2R (OX2R knockout mice), as well as those
in which orexin-expressing neurones were deleted (orexin⁄ataxin-3
transgenic mice), demonstrate a phenotype remarkably similar to
the human sleep disorder narcolepsy (10–12). Additionally, prepro-
orexin mRNA was not detected in the brain of a human with
narcolepsy (13). Taken together, these data suggest that the orex-
in system plays a critical role regulating the sleep–wake cycle,
and it appears to be particularly important for maintaining wake-
fulness.
In this review, we discuss several recent studies of transgenic
mice in which orexin neurones express different ﬂuorescent mole-
cules, including enhanced green ﬂuorescent protein (EGFP; orex-
in⁄EGFP mice), a calcium-sensing protein, yellow cameleon
(orexin⁄YC2.1 mice), and a retrograde tracer, tetanustoxin C-termi-
nal fragment (orexin⁄TTC::GFP mice). Additionally, a novel optoge-
netic approach has demonstrated the importance of neuronal
activity of orexin in the regulation of sleep⁄wakefulness in vivo.
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Orexin is a neuropeptide produced by a speciﬁc subset of neurones located in the lateral hypo-
thalamic area. Mice lacking either prepro-orexin or orexin receptor 2, as well as those in which
orexin-producing neurones (orexin neurones) are deleted, share a common phenotype: altered
sleep–wake regulation and the sudden onset of muscle atonia. These symptoms are similar to
the human sleep disorder narcolepsy. In this review, we describe recent advances in the study
of orexin function with a particular emphasis on microscopic techniques that better characterise
the neuronal networks involving orexin neurones, as well as recent optogenetic approaches that
allow for the activation or inhibition of speciﬁc neurones by expressing different light-activated
proteins. In particular, the use of orexin⁄halorhodopsin and orexin⁄channelrhodopsin-2 trans-
genic mice has demonstrated an important role for orexin neurones in regulating the sleep–
wake cycle and state of arousal in vivo. Further reﬁnement of these in vitro and in vivo tech-
niques will allow for a more detailed understanding of the interaction of orexin with other neu-
rotransmitter pathways in the brain.
Key words: neuropetides, receptors, membrane⁄nuclear, noradrenaline, 5-HT, CCK, vasopressin.
doi: 10.1111/j.1365-2826.2010.02015.x
Journal of Neuroendocrinology 22, 818–824
ª 2010 The Authors. Journal Compilation ª 2010 Blackwell Publishing Ltd
Journal of Neuroendocrinology
From Molecular to Translational NeurobiologyRegulatory mechanisms of orexin neurones revealed
through the slice patch clamp technique
Electrophysiological techniques (e.g. the slice patch clamp) have
proved invaluable for the study of neuronal membrane properties
and input pathways. However, the small number of orexin neurones
(approximately 4000 cells⁄mice brain) sparsely distributed through
the LHA make them poor candidates for electrophysiological analy-
ses. Additionally, they lack morphologic and electrophysiological
features that allow them to be easily distinguished from other neu-
rones. To better identify orexin neurones, transgenic mice express-
ing EGFP under the control of the orexin promoter were generated
(14, 15). The orexin promoter is a 3.2-kb region of DNA upstream
of the human prepro-orexin gene (Fig. 1A). This genomic fragment
has two phylogenetically conserved regions located 287 bp and
2.5 kb upstream of the transcription initiation site of the human
prepro-orexin gene (16), and this promoter enables the expression
of genes speciﬁcally in orexin neurones. In the brains of these
transgenic mice, EGFP was expressed by approximately 90% of
orexin neurones (Fig. 1B), and no ectopic EGFP expression was
observed throughout the brain. Once generated, we were able to
perform electrophysiological studies of orexin neurones (Fig. 1C),
and we ﬁrst examined the effects of the fast neurotransmitters,
glutamate and GABA, on orexin neurones. Ionotropic glutamate
receptor agonists (AMPA and NMDA) depolarised orexin neurones,
but GABAA (muscimol) and GABAB (baclofen) receptor agonists hy-
perpolarised orexin neurones (14, 17). Additionally, neurotransmit-
ters implicated in sleep–wake regulation were applied to orexin
neurones. Serotonergic (5-hydroxytryptamine; 5-HT) neurones in
the DR, noradrenergic neurones in the LC and histaminergic neuro-
nes in the TMN play important roles in the regulation of sleep and
wakefulness. These nuclei are densely innervated by orexin neurones
and activated by orexin (4–8), and Table 1 summarises the com-
pounds reported to affect the activity of orexin neurones. Both
5-HT and noradrenaline hyperpolarise all orexin neurones through
the G-protein-coupled inwardly rectifying potassium channels
downstream of 5-HT1A receptors and a2A receptors, respectively
(Fig. 1D) (18, 19). Interestingly, histamine appears to have no effect
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Fig. 1. Electrophysiological analyses of orexin neurones using orexin⁄EGFP mice. (A) Structure of the orexin⁄EGFP transgene. (B) Orexin immunoreactive (-ir)
(middle) and enhanced green ﬂuorescent protein (EGFP)-positive (left) neurones are located in the lateral hypothalamic area, and colocalise in the merged
image (right). (C) Identiﬁcation of orexin neurones using EGFP ﬂuorescence in a hypothalamic slice preparation from an orexin⁄EGFP transgenic mouse. EGFP
ﬂuorescence (left) and infrared differential interference contrast (right) images (Scale bar = 20 lm). (D) Under current clamp mode, 5-hydroxytryptamine (5-HT)
(100 lM) and noradrenaline (100 lM) application induced hyperpolarisation in all orexin neurones, but carbachol (100 lM), an acetylcholine receptor agonist,
induced depolarisation in 27% of orexin neurones. (E) Under current clamp mode, cholecystokinin (CCK-8S) (100 nM) and arginine-vasopressin (AVP) (100 nM)
application induced depolarisation and an increased ﬁring rate in the orexin neurones. (B, C, D) Reproduced with permission [14].
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nist, variably affects orexin neurones; carbachol activates 27% of
orexin neurones and inhibits 6% of orexin neurones (Fig. 1D) (14,
20). The cholinergic nuclei (laterodorsal tegmental nucleus and
peduncle pontine nucleus) have been implicated in the regulation
of rapid eye movement (REM) sleep and arousal (21). Alternatively,
cholinergic neurones in the basal forebrain may maintain wakeful-
ness (22). Carbachol-induced activation of orexin neurones is medi-
ated through M3 receptors (23), although the inhibitory receptors
remain unknown. However, M2 and⁄or M4 receptors are likely to be
involved because they are coupled to inhibitory Gi⁄Go type G pro-
teins, whereas M1,M 3 and M5 receptors are coupled to Gq⁄G11
type G proteins signalling molecules (24).
Neuropeptidergic regulation of orexin neurones
To better characterise endogenous ligands affecting the activity of
orexin neurones, transgenic mice were generated that speciﬁcally
express the calcium-sensing protein, yellow cameleon 2.1 (YC2.1)
(orexin⁄YC2.1 transgenic mice) in orexin neurones (25). This system
allowed us to monitor the activity of several orexin neurones simul-
taneously using ﬂuorescence resonance energy transfer in slice
preparations. Neuropeptides are considered to play important roles
regulating feeding, drinking and sleep⁄wakefulness (26–29). The
effects of neuropeptides were examined using calcium imaging of
orexin neurones. Among the tested neuropeptides, a sulfated octa-
peptide form of cholecystokinin (CCK-8S), neurotensin (NT), oxytocin
and arginine-vasopressin (AVP) activated orexin neurones, but noci-
ceptin inhibited the activity of orexin neurones (25). CCK-8S- and
AVP-induced activation of orexin neurones was also studied by slice
patch clamp experiments (Fig. 1E). CCK-8S-induced depolarisation
and inward currents were mediated by the CCKA receptor, and the
increased intracellular calcium concentration observed after CCK-8S
stimulation was the result of calcium inﬂux through the nonselec-
tive cation channel (NSCC). By contrast, AVP-induced depolarisation
and inward currents were mediated by the V1a receptor, which is
coupled to Gq⁄G11 type G-proteins (30). The subsequent activation
of phospholipase Cb increases the intracellular calcium concentra-
tion by stimulating both calcium inﬂux through the NSCC and cal-
cium release from intracellular stores.
Behavioural experiments were performed to better understand
the physiological signiﬁcance of the AVP-induced activation of or-
exin neurones. Mice were generated in which Ataxin-3 (CAG repeat
region in the ataxin-3 gene) was expressed under the control of
the orexin promoter (orexin⁄ataxin-3 mice), leading to the speciﬁc
ablation of orexin neurones. Intracerebroventricular injection of AVP
or water deprivation increased spontaneous locomotor activity in
wild-type mice, but not in orexin⁄ataxin-3 mice (10). AVP is an
anti-diuretic hormone released during dehydration, and these
results suggest that the orexin system plays a key role in water
deprivation-induced hyperlocomotor activity. Additionally, a previ-
ous study showed that food deprivation induced hyperlocomotor
activity, especially exploratory activity, through the activation of or-
exin neurones (15). Food deprivation is considered to decrease the
extracellular glucose concentration, leading to increased ghrelin
concentrations, and, ultimately, the depolarisation of orexin neuro-
nes (Table 1). By contrast, increasing extracellular glucose and leptin
concentrations leads to hyperpolarisation of the orexin neurones
(15) (Fig. 2). When considered together with the well documented
role of orexin neurones in maintaining wakefulness, these results
suggest that reduced food and⁄or water availability (in emergency
situations) leads to increased arousal downstream of the activation
of orexin neurones. Consistent with this, in mice placed on
restricted feeding schedules (i.e. food access is limited to a few
hours a day), orexin neurones become activated immediately pre-
ceding food access (31) and food-seeking behaviour is absent in
orexin⁄ataxin-3 mice (32). However, the precise physiological role
of orexin neurones in maintaining water or energy homeostasis
remains unclear. It is possible that increased spontaneous locomo-
tor activity and arousal may lead animals to expand their territories
aiming to increase the chance of ﬁnding food or a new water
source. It will be interesting to parse out the evolutionary implica-
tions of this system and its contribution to increased survival in
nature.
By contrast, orexin neurones are activated by corticotrophin-
releasing factor (CRF) (33) and thyrotropin-releasing hormone (TRH)
(34) via the CRF R1 and TRH-R1 receptors, respectively. CRF-
induced activation of orexin neurones might be involved in stress-
induced increases in arousal or insomnia, whereas TRH-induced
activation of orexin neurones may be related to locomotor activity,
thermoregulation and sleep⁄wakefulness regulation.
Table 1. Substances which affect the activity of orexin neurones.
Substances Receptor Reference
Activation
Glutamate AMPA, NMDA (12)
Acetylcholine M3 (12, 17, 20)
Cholecystokinin CCKA (22)
Arginine-vasopressin V1a (22, 23)
Oxytocin V1a (22, 23)
Neurotensin ? (22)
Ghrelin GHSR (13)
Thyrotropin-releasing hormone TRH-R1 (35)
Glucagon-like peptide-1 GLP-1R (36)
Corticotrophin-releasing factor CRFR1 (37)
ATP P2X (38)
CO2 ? (39)
H
+ ? (39)
Inhibition
GABA GABAA, GABAB (12, 14)
5-Hydroxytryptamine 5-HT1A (15)
Noradrenaline a2A (16)
Dopamine a2A (16)
Acetylcholine ? (12)
Glucose ? (13, 40, 41)
Leptin OB-R (13)
Neuropeptide Y Y1 (42)
Adenosine A1 (43)
Nociceptin NOP (44)
Met-enkephalin l (45)
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To better understand the interaction of orexin neurones with
other neurones implicated in the regulation of sleep⁄wakefulness,
transgenic mice expressing a retrograde tracer, nontoxic C-termi-
nal fragment of tetanus toxin (TTC::GFP), exclusively in orexin
neurones were generated (20). TTC::GFP was selectively retro-
gradely transferred to interconnected neurones and transported to
the cell bodies of higher-order neurones. Using this system, we
were able to map upstream neuronal populations with direct syn-
aptic connections to orexin neurones. TTC::GFP-labelled cells were
identiﬁed in multiple areas of the brain, including serotonergic
neurones in the median raphe nuclei and GABAergic neurones in
the ventrolateral preoptic nucleus (VLPO), a known sleep centre.
These observations suggest that neurones in these locations send
inhibitory projections to orexin neurones because electrophysiolog-
ical studies revealed that GABA and 5-HT inhibit all orexin neuro-
nes. Serotonergic innervation may act as a negative feedback
system to maintain orexin neuronal activity within appropriate
ranges. The sleep-active GABAergic neurones in the VLPO play an
important role in the initiation and maintenance of slow wave
sleep (SWS), and these neurones are activated by putative sleep
promoting factors, including adenosine and prostagrandin D2 (35,
36). An electrophysiological study revealed that GABA inhibits or-
exin neurones through both GABAA and GABAB receptors (14, 17,
20, 37), suggesting that sleep-active neurones in the VLPO send
GABAergic inhibitory projections to orexin neurones. This circuit
may inhibit the activity of orexin neurones during sleep, and the
reciprocal interactions between orexin neurones and these nuclei
may be important for maintaining the balance of sleep and wake-
fulness.
In addition to known sleep centres, TTC::GFP labelled neurones
were also found in the amygdala, infralimbic cortex, accumbens
nucleus, lateral septum and bed nucleus of the stria terminalis.
These regions contribute to the generation of mood and emotion,
and neurones in these nuclei produce neuropeptides that activate
orexin neurones such as CCK, NT and AVP. Inputs from these nuclei
activate orexin neurones and may be involved in emotion-induced
increases in arousal.
Optical control of orexin neuronal activity in vivo
Taken together, slice patch clamp, calcium imaging and anatomical
studies can be combined to generate a map of afferent neurones
to orexin neurones (Fig. 2). Information obtained from these studies
has expanded our understanding of the regulatory mechanisms
governing sleep⁄wakefulness. However, it remains unclear how
these networks interact in vivo to control the state of arousal of
animals, and a recently developed optogenetics approach has
already began to address these questions.
The microbial proteins channelrhodopsin-2 (ChR2) and halo-
rhodopsin (HaloR) isolated from Chlamydomonas reinhardtii and
Natronomonas pharaonis, respectively, respond to different wave-
lengths of light, and they have been used to control the polarisa-
tion of neurones after exposure to light (38–41). ChR2 is a
monovalent cation channel, and exposure to blue light (470 nm)
depolarises the membrane potential of ChR2-expressing cells. By
contrast, HaloR is a chloride pump activated by orange light
(580 nm). Activation of HaloR leads to an inﬂux of chloride ions
and hyperpolarises the membrane potential of HaloR-expressing
cells (Fig. 3A). Thus, the expression of these proteins enables the
control of neuronal activity by illuminating cells or animals with
speciﬁc wavelengths of light, and these proteins can be expressed
using tissue speciﬁc promoters in animals (Fig. 3B). Thus, ChR2
expression was genetically targeted to orexin neurones using
lentiviral vectors in mice (42). In slice preparations, the ﬁring
frequency of ChR2-expressing orexin neurones was increased after
exposure to pulsed blue light (up to 20 Hz). To study the role of
LDT
PPN
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neurotensin
Nociceptin
oxytocin
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TMN Orexin
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Fig. 2. Interaction of orexin neurones with other neurones implicated in the regulation of sleep⁄wakefulness. The dashed blue line shows inhibitory projec-
tions, and the red arrow shows excitatory projections. AVP, arginine-vasopressin; BF, basal forebrain; CCK-8S, cholecystokinin; DMH, dorsomedial hypothalamic
nucleus; DR, dorsal raphe nuclei; LC, locus coeruleus; LDT, laterodorsal tegmental nucleus; PPN, peduncle pontine nucleus; SCN, suprachiasmatic nucleus; TMN,
tuberomammillary nucleus; VLPO, ventrolateral preoptic nucleus.
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myographic (EMG) electrodes were implanted in freely moving mice
to determine the sleep⁄wakefulness stage, and ﬁbre optics were
implanted in the LHA to stimulate orexin neurones by light.
Photostimulation of orexin neurones at a frequency of 5–30 Hz
increased the total time of wakefulness and signiﬁcantly reduced
the amount of time spent in SWS and REM sleep in ChR2-express-
ing mice (42). This was the ﬁrst study that used optogenetics to
successfully control animal behaviour. These results suggest that
orexin neurones can induce arousal in concert with other neuro-
transmitter systems such as the noradrenergic, serotonergic, cholin-
ergic, histaminergic and dopaminergic systems. A subsequent study
examined whether orexin-mediated sleep–wake transitions are
affected by the light⁄dark period and sleep pressure. Photostimula-
tion of ChR2-expressing orexin neurones was sufﬁcient to increase
the sleep–wake transitions for both SWS and REM sleep. Addition-
ally, although photostimulation increased c-Fos expression in the
orexin neurones consistent with an increase in neuronal activity,
sleep deprivation (increasing sleep pressure) diminished the arousal
effect induced by the photostimulation of orexin neurones (43).
This study suggests that the activation of orexin neurones pro-
motes wakefulness independently from light⁄dark period, but
photostimulation of orexin neurones cannot overcome an increase
in sleep pressure.
To further deﬁne the role of orexin neurones in regulating
arousal, we examined whether silencing of the activity of orexin
neurone affects sleep–wake transitions by generating transgenic
mice in which orexin neurones express HaloR (orexin⁄HaloR mice).
Immunohistochemical analysis conﬁrmed that more than 90% of
orexin-immunoreactive neurones express HaloR (Fig. 3C), and the
functionality of this inactivation strategy was conﬁrmed by slice
patch clamp experiments performed in vitro. HaloR-expressing
ChR2
K+
HaloR
Na+ Cl–
Optical stimulation Electrical stimulation
Orexin-IR GFP-IR Merge
20 mV
5 s
(A)( B)
(C)
(D)( E)
(F)
Fig. 3. Control of orexin neuronal activity by light-activated proteins. (A) Activation of channelrhodopsin-2 (ChR2) by illumination with blue light induces
depolarisation and generates action potentials (left). Activation of halorhodopsin (HaloR) by illumination with orange light induces hyperpolarisation and blocks
action potentials (right). (B) Nonspeciﬁc stimulation by electrical stimulation (right). Speciﬁc neurones expressing light-activated proteins are stimulated by
exposure to the appropriate wavelength of light (left). (C) HaloR is speciﬁcally expressed in the orexin neurones in the orexin⁄Halo transgenic mouse brain. Or-
exin immunoreactive (-ir) neurones are located in the lateral hypothalamic area (LHA) (red, right), and green ﬂuorescent protein-positive neurones, indicating
Halo expression, are also present in the LHA (green, middle). Scale bar = 500 lm. (D) Neurones are exposed to orange light through an objective lens. (E) Under
current clamp mode, illumination with orange light induces hyperpolarisation and inhibits spontaneous action potentials in HaloR-expressing orexin neurones
in the orexin⁄Halo transgenic mice. (F) To control the activity of orexin neurones, ﬁbre optics (0.5 mm in diameter) are bilaterally implanted.
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N-terminus of HaloR, and, under current clamp mode, the mem-
brane potential of orexin neurones was recorded when orange light
was applied through an objective lens (Fig. 3D). Exposure to orange
light hyperpolarised the membrane potential by approximately
15 mV and blocked spontaneous ﬁring by orexin neurones (Fig. 3E).
Similar to the ChR2 experiments, ﬁbre optics (0.5 mm diameter)
were implanted bilaterally into the LHA, and EEG and EMG were
simultaneously recorded to determine the sleep–wake state (Fig. 3F).
Exposure of orexin neurones to orange light induced SWS in mice
(i.e. decreased EMG and increased EEG delta power). Taken together,
the ChR2 and HaloR experiments suggest that the stability of arou-
sal may result from the activity of orexin neurones in conjunction
with other arousal-promoting circuits, including the serotonergic
DR, histaminergic TMN and noradrenergic LC.
Optogenetics is a powerful new tool allowing researchers to con-
trol the activity of speciﬁc neurones in vitro and in vivo. However,
there are technical concerns that may limit the applicability of
these techniques to all neurone types. In particular, in vivo phot-
ostimulation requires a strong light source such as a high power
laser (100–1000 mW) and a ﬁbre optics tethering system to guide
the light to speciﬁc brain areas. However, such intense light may
lead to thermal injury of local neurones. Optogenetic studies also
require a speciﬁc and strong promoter to allow for the tight control
of expression observed in orexin neurones. A combination of cre-
loxP or FLP-FRT systems may enhance the expression of light-acti-
vated proteins under the control of weak promoters (44). Addition-
ally, repeated and⁄or continuous exposure to light quickly
inactivates the light-activated proteins, and this may be problematic
for the application of optogenetics to relatively slow and long last-
ing physiological processes such as the control of neuroendocrine
pathways. Although these problems need to be overcome for the
broader applicability of these techniques, light-activated proteins
are being rapidly discovered and engineered to increase their utility
and potency (45, 46). Indeed, a new type of light-activated proton
pumps, archaerhodopsin-3 (Arch), was very recently isolated from
Halorubrum sodomense (47). Arch is a proton export pump and
induces a more sustained and stable state of hyperpolarisation than
HaloR. Optimisation of existing proteins and discovery of new
molecules will improve optogenetical techniques and enable the
more complete control of neuronal activity.
Conclusions
Orexin neurones play important roles in the regulation of feeding,
drinking, endocrine function and sleep⁄wakefulness. As discussed
above, neural networks formed between orexin neurones and other
neurones have been electrophysiologically and anatomically studied
using several transgenic mice. Orexin neurones receive many excit-
atory and inhibitory inputs, and project to several sites after inte-
grating these signals. However, it remains unclear how these
networks interact and regulate animal behaviour in vivo. Our ability
to control the activity of speciﬁc types of neurones in vivo using
optogenetics will allow for the development of new research ave-
nues to connect neural activity and behaviour.
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